Marshall Wace
IMCR icon

Marshall Wace’s Immunocore IMCR Stock Holding History

Marshall Wace’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.44M Buy
180,340
+119,177
+195% +$3.86M 0.01% 1266
2025
Q4 		$2.12M Sell
61,163
-62,079
-50% -$2.19M ﹤0.01% 1547
2025
Q3 		$4.48M Sell
123,242
-23,368
-16% -$794K ﹤0.01% 1229
2025
Q2 		$4.6M Buy
146,610
+118,728
+426% +$3.69M 0.01% 1182
2025
Q1 		$827K Sell
27,882
-728
-3% -$21.8K ﹤0.01% 1865
2024
Q4 		$844K Sell
28,610
-170,833
-86% -$5.4M ﹤0.01% 1812
2024
Q3 		$6.21M Sell
199,443
-49,211
-20% -$1.79M 0.01% 916
2024
Q2 		$8.43M Buy
248,654
+30,703
+14% +$1.57M 0.01% 811
2024
Q1 		$14.2M Buy
+217,951
New +$15M 0.02% 629
2023
Q4 		– Sell
-85,639
Closed -$4.44M – 2367
2023
Q3 		$4.44M Sell
85,639
-3,165
-4% -$187K 0.01% 918
2023
Q2 		$5.32M Buy
88,804
+64,684
+268% +$3.69M 0.01% 995
2023
Q1 		$1.19M Sell
24,120
-6,260
-21% -$352K ﹤0.01% 1729
2022
Q4 		$1.73M Buy
30,380
+6,260
+26% +$352K ﹤0.01% 1797
2022
Q3 		$1.13M Hold
24,120
– – ﹤0.01% 2347
2022
Q2 		$900K Hold
24,120
– – ﹤0.01% 2504
2022
Q1 		$721K Hold
24,120
– – ﹤0.01% 2603
2021
Q4 		$826K Buy
+24,120
New +$873K ﹤0.01% 2558

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Marshall Wace's IMCR Position: Q1 2026 in Review

Marshall Wace increased its Immunocore (IMCR) stake by 195% in Q1 2026, buying an estimated $3.86M and bringing the position to 180,340 shares worth $5.44M. The position accounts for 0.01% of the portfolio, ranked #1266.

Marshall Wace first reported a position in IMCR in Q4 2021 and has held it in 17 quarters since. The position peaked at $14.2M in Q1 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Marshall Wace held 180,340 shares of Immunocore worth $5.44M as of Q1 2026.
  • Marshall Wace bought 119,177 Immunocore shares in Q1 2026, an estimated $3.86M.
  • Immunocore made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1266 holding.
  • Marshall Wace first reported a position in Immunocore in Q4 2021 and has held it in 17 quarters since.
  • Marshall Wace's Immunocore position peaked at $14.2M in Q1 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.